Literature DB >> 10924313

Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure.

H J Crijns1, G Tjeerdsma, P J de Kam, F Boomsma, I C van Gelder, M P van den Berg, D J van Veldhuisen.   

Abstract

AIMS: To examine whether the presence, or development, of atrial fibrillation in patients with advanced chronic heart failure, is associated with a poorer prognosis, compared to patients with sinus rhythm and chronic heart failure. METHODS AND
RESULTS: We examined 409 patients with moderate to severe chronic heart failure, and compared patients with sinus rhythm (n=325) to those with atrial fibrillation (n=84). At baseline, the two groups were similar regarding most indices of severity of chronic heart failure, such as left ventricular ejection fraction (0.23) and New York Heart Association (NYHA) functional class, while they were different for age (70 years for atrial fibrillation vs 67 years for sinus rhythm patients), aetiology of chronic heart failure, blood pressure, concomitant treatment, and plasma neurohormones (all P<0.05). During a mean follow-up of 3.4 years (range 2.0-5.4), 203 patients (50%) died. The majority of deaths was due to progressive chronic heart failure (55%) or was sudden (28%), but there was no difference in mode of death between sinus rhythm and atrial fibrillation patients. Overall mortality was higher in atrial fibrillation patients (60%), than in those with sinus rhythm (47%; risk ratio 1.40, 95% CI 1.01-1.92, P=0. 04). After adjusting for important prognostic variables, such as age, left ventricular ejection fraction, NYHA class, renal function, and blood pressure, the presence of atrial fibrillation was no longer related to increased mortality (risk ratio 0.86, range 0.59-1.24, P=ns). Of the 325 patients who had sinus rhythm at baseline, 30 (9%) developed atrial fibrillation during the study. These patients were older (70 vs 66 years, P<0.007), and had slightly lower blood pressure and plasma norepinephrine concentrations (P<0.05), but were otherwise similar. During follow-up, mortality was similar in these two groups (47% in those with new onset atrial fibrillation, vs 47% in those who had sinus rhythm throughout the study).
CONCLUSIONS: The present data do not support the concept that the presence, or the development of atrial fibrillation in patients with advanced chronic heart failure is independently related to an adverse outcome during long-term follow-up. The generally observed higher mortality in patients with atrial fibrillation thus seems to be related to other factors, associated with atrial fibrillation. Copyright 2000 The European Society of Cardiology.

Entities:  

Mesh:

Year:  2000        PMID: 10924313     DOI: 10.1053/euhj.1999.2107

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  34 in total

Review 1.  Computational approaches to structural and functional analysis of plastocyanin and other blue copper proteins.

Authors:  F De Rienzo; R R Gabdoulline; R C Wade; M Sola; M C Menziani
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

2.  Prognostic significance of atrial fibrillation is a function of left ventricular ejection fraction.

Authors:  Ramdas G Pai; Padmini Varadarajan
Journal:  Clin Cardiol       Date:  2007-07       Impact factor: 2.882

Review 3.  Do arrhythmias still deserve our intellectual efforts?: The 2002 Wenckebach Lecture of the Netherlands Society of Cardiology.

Authors:  N M van Hemel
Journal:  Neth Heart J       Date:  2003-08       Impact factor: 2.380

4.  Advanced Interatrial Block Predicts New Onset Atrial Fibrillation in Patients with Severe Heart Failure and Cardiac Resynchronization Therapy.

Authors:  Fariha Sadiq Ali; Andres Enriquez; Diego Conde; Damian Redfearn; Kevin Michael; Christopher Simpson; Hoshiar Abdollah; Antoni Bayés de Luna; Wilma Hopman; Adrian Baranchuk
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-02-02       Impact factor: 1.468

5.  Impact of atrial fibrillation on outcome of patients with idiopathic dilated cardiomyopathy: data from the Heart Muscle Disease Registry of Trieste.

Authors:  Aneta Aleksova; Marco Merlo; Massimo Zecchin; Gastone Sabbadini; Giulia Barbati; Giancarlo Vitrella; Andrea Di Lenarda; Gianfranco Sinagra
Journal:  Clin Med Res       Date:  2010-08-03

6.  Atrial fibrillation and mortality in heart failure: a community study.

Authors:  Alanna M Chamberlain; Margaret M Redfield; Alvaro Alonso; Susan A Weston; Véronique L Roger
Journal:  Circ Heart Fail       Date:  2011-09-15       Impact factor: 8.790

7.  Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation.

Authors:  David P Kao; Gordon Davis; Ryan Aleong; Christopher M O'Connor; Mona Fiuzat; Peter E Carson; Inder S Anand; Jonathan F Plehn; Stephen S Gottlieb; Marc A Silver; JoAnn Lindenfeld; Alan B Miller; Michel White; Guinevere A Murphy; Will Sauer; Michael R Bristow
Journal:  Eur J Heart Fail       Date:  2012-12-07       Impact factor: 15.534

Review 8.  Pathophysiology of concomitant atrial fibrillation and heart failure: implications for management.

Authors:  T Ben Morrison; T Jared Bunch; Bernard J Gersh
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-12-02

Review 9.  Resynchronization therapy in the context of atrial fibrillation: benefits and limitations.

Authors:  Uta C Hoppe
Journal:  J Interv Card Electrophysiol       Date:  2007-04-21       Impact factor: 1.900

10.  A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study.

Authors:  Mustafa I Ahmed; Michel White; O James Ekundayo; Thomas E Love; Inmaculada Aban; Bo Liu; Wilbert S Aronow; Ali Ahmed
Journal:  Eur Heart J       Date:  2009-06-16       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.